| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0053 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.00086 | 1 |